Income Statement (TTM)
Pulse Biosciences, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 2 | 2 | 1 | 0 | -0 | -0 |
| Change (%) | 147.04 | 31.31 | 14.23 | -26.99 | -54.93 | -63.43 | -103.52 | -0.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 2 | 3 | 4 | 12 | 12 | 11 | 10 | 1 |
| Change (%) | 170.70 | 46.19 | 46.72 | 181.78 | 0.42 | -7.61 | -12.18 | -86.68 | |
| % of Revenue | 126.66 | 138.79 | 154.51 | 198.45 | 765.87 | 1,706.29 | 4,310.55 | -107,677.78 | -14,344.44 |
| Gross Operating Profit | -0 | -1 | -1 | -2 | -10 | -11 | -11 | -10 | -1 |
| Change (%) | 259.48 | 84.55 | 106.31 | 393.84 | 8.73 | -4.14 | -10.01 | -86.60 | |
| % of Revenue | -26.66 | -38.79 | -54.51 | -98.45 | -665.87 | -1,606.29 | -4,210.55 | 107,777.78 | 14,444.44 |
| SG&A | 31 | 34 | 34 | 35 | 32 | 26 | 20 | 16 | 14 |
| Change (%) | 9.82 | 1.71 | 0.38 | -7.39 | -18.78 | -24.28 | -20.07 | -8.45 | |
| % of Revenue | 5,365.85 | 2,385.33 | 1,847.53 | 1,623.46 | 2,059.18 | 3,710.57 | 7,682.81 | -174,677.78 | -159,922.22 |
| R&D | 30 | 29 | 26 | 24 | 22 | 21 | 20 | 21 | 24 |
| Change (%) | -5.81 | -8.01 | -7.60 | -7.98 | -6.98 | -4.51 | 6.23 | 13.98 | |
| % of Revenue | 5,297.39 | 2,019.75 | 1,414.93 | 1,144.57 | 1,442.50 | 2,977.00 | 7,773.05 | -234,866.67 | -267,700.00 |
| OpEx | 62 | 64 | 64 | 63 | 66 | 59 | 51 | 47 | 40 |
| Change (%) | 4.03 | -1.25 | -0.83 | 5.04 | -11.34 | -13.88 | -8.01 | -14.55 | |
| % of Revenue | 10,789.90 | 4,543.86 | 3,416.97 | 2,966.48 | 4,267.55 | 8,393.86 | 19,766.41 | -517,222.22 | -441,966.67 |
| Operating Income | -61 | -63 | -62 | -61 | -65 | -58 | -50 | -47 | -40 |
| Change (%) | 2.70 | -1.99 | -1.28 | 6.15 | -10.30 | -13.28 | -7.52 | -14.55 | |
| % of Revenue | -10,689.90 | -4,443.86 | -3,316.97 | -2,866.48 | -4,167.55 | -8,293.86 | -19,666.41 | 517,322.22 | 442,066.67 |
| Interest Expense | -1 | -1 | -1 | -0 | -0 | -1 | -1 | -1 | -1 |
| Change (%) | 9.38 | -16.29 | -88.23 | -13.04 | 1,400.00 | 26.56 | -20.98 | -0.00 | |
| % of Revenue | -111.50 | -49.37 | -31.47 | -3.24 | -3.86 | -128.57 | -444.92 | 10,000.00 | 10,000.00 |
| Net Income | -62 | -64 | -62 | -61 | -65 | -59 | -51 | -47 | -39 |
| Change (%) | 2.69 | -2.15 | -2.13 | 6.16 | -9.61 | -12.77 | -8.01 | -15.92 | |
| % of Revenue | -10,800.35 | -4,489.42 | -3,345.54 | -2,866.34 | -4,167.68 | -8,357.86 | -19,934.77 | 521,633.33 | 438,600.00 |
Source: Capital IQ
